Jubilant Pharmova balance sheet

·Pharma & HealthChart ›
As of Mar 2026
Total assets
₹15,523cr+21.7% on Mar 2025
Shareholders' equity
₹7,096cr+13.7% on Mar 2025
Total debt
₹3,220cr+32.1% on Mar 2025
Cash and investments
₹1,267cr+16.4% on Mar 2025
₹ crore except per share
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Non-current assets
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
3,5102,1322,1582,298
2,9622,7151,252773
2,8262,5412,4642,429
198181193457
1,079915851788
0.87.57.8224
60.636.034.432.8
0.30.30.30.4
30.426.619.818.4
91.362.954.551.6
257257233227
490367460147
11,4139,1797,6727,394
Current assets
1,2321,1291,2901,381
1,070892916961
1,2671,0889561,014
0.50.50.40.4
1.91.10.81.1
219161247129
2,5582,1422,1212,106
249221205265
4,1093,5103,6323,762
—67.5244—
15,52312,75611,54911,157
Equity
15.815.815.815.9
7,0776,2395,4185,383
7,0936,2555,4345,399
2.8−16.3−12.8−7.5
7,0966,2395,4215,392
Liabilities
2,9722,1503,1673,110
1,134774217215
4,1062,9243,3843,325
16011910092.3
251172211306
1,3721,138544269
5,8884,3534,2383,992
248287247300
1,2341,005856821
602574519389
2,0841,8661,6221,510
94.378.466.478.4
20.118.437.062.4
340202163122
2,5392,1651,8891,772
8,4276,5186,1275,765
15,52312,75611,54911,157
Assets — additional as-filed lines
70.818.016.711.5
Trade payables — MSME split
23.034.3——
1,211971——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

JUBLPHARMA₹946.00

Jubilant Pharmova Ltd.

· Pharma & Health
₹ CrorePeersGLANDPPLPHARMAKIMSINDGNONESOURCEGRANULESPFIZERPOLYMEDMcap ₹14,947 Cr
View
In ₹ Crore except Per Share
As of
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment2,297.52,157.82,132.33,509.63,509.6
+ Capital Work-in-Progress773.31,252.32,714.72,961.52,961.5
+ Goodwill2,428.62,463.92,541.02,826.12,826.1
+ Other Intangibles457.1192.5181.4197.7197.7
+ Intangibles under Development788.2850.8915.31,078.91,078.9
+ Investments (Equity Method)223.67.87.50.80.8
+ Non-current Investments32.834.436.060.660.6
+ Long-term Loans0.40.30.30.30.3
+ Other Non-current Financial Assets18.419.826.630.430.4
Non-current Financial Assets51.654.562.991.391.3
+ Deferred Tax Assets227.4232.7257.4257.1257.1
+ Other Non-current Assets146.8460.1366.7490.4490.4
Total Non-current Assets7,394.37,672.49,179.211,413.411,413.4
Current Assets
+ Inventories1,380.51,289.61,129.21,231.51,231.5
+ Trade Receivables961.2915.9891.51,069.61,069.6
+ Cash & Cash Equivalents1,013.9956.41,088.31,267.11,267.1
+ Other Bank Balances0.40.40.50.50.5
+ Short-term Loans1.10.81.11.91.9
+ Other Current Financial Assets129.0247.4160.5218.9218.9
Current Financial Assets2,105.72,120.92,141.92,558.02,558.0
+ Other Current Assets264.6205.0220.6249.0249.0
Total Current Assets3,762.43,632.23,509.74,109.34,109.3
+ Assets Held for Sale—243.967.5——
Total Assets11,156.711,548.512,756.415,522.715,522.7
Equity
+ Equity Share Capital15.915.815.815.815.8
+ Other Equity / Reserves5,383.45,418.16,239.17,077.07,077.0
Equity — Owners of Parent5,399.35,433.96,254.97,092.87,092.8
+ Minority Interest-7.5-12.8-16.32.82.8
Total Equity5,391.85,421.16,238.67,095.67,095.6
Liabilities
+ Borrowings — Non-current3,110.43,167.12,150.32,971.72,971.7
+ Other Non-current Financial Liab215.1216.6774.11,134.31,134.3
Non-current Financial Liabilities3,325.53,383.72,924.44,106.04,106.0
+ Provisions — Non-current92.3100.1119.1159.5159.5
+ Deferred Tax Liabilities306.2210.8172.2250.7250.7
+ Other Non-current Liabilities268.5543.81,137.51,372.01,372.0
Non-current Liabilities3,992.54,238.44,353.25,888.25,888.2
+ Borrowings — Current299.7247.0286.6247.8247.8
+ Trade Payables821.3856.31,004.81,234.11,234.1
+ Other Current Financial Liab388.9519.1574.3602.3602.3
Current Financial Liabilities1,509.91,622.41,865.72,084.22,084.2
+ Provisions — Current78.466.478.494.394.3
+ Current Tax Liabilities62.437.018.420.120.1
+ Other Current Liabilities121.8163.2202.1340.3340.3
Current Liabilities1,772.41,889.02,164.62,538.92,538.9
Total Liabilities5,764.96,127.46,517.88,427.18,427.1
Total Equity & Liabilities11,156.711,548.512,756.415,522.715,522.7
Assets — additional as-filed lines
+ Current Tax Assets11.516.718.070.870.8
Trade Payables — MSME split
+ Dues to Micro & Small — Current——34.323.023.0
+ Dues to Other Creditors — Current——970.51,211.11,211.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.